liveBook · Manning

Compound library

As explained in Build AI Drug Discovery Pipelines

A compound library is a curated collection of chemical compounds available for screening or analysis.

A compound library is a curated collection of chemical molecules assembled for screening or analysis. In virtual screening, it provides the search space from which computational methods select promising drug candidates. section 2.1 section 2.1.2

A practical library workflow loads molecular datasets, checks molecules for errors or poor quality, filters undesirable properties such as toxicity risk, and calculates molecular descriptors before screening. section 2.1.2 section 2.2

Libraries can be assembled in several ways:

  • Public or commercial catalogs provide immediately available molecules, including purchasable or synthesizable compounds. section 2.1.2
  • Custom or enumerated libraries generate analogs from known scaffolds or reaction rules, expanding chemical-space coverage while increasing synthesis demands. section 2.1.2
  • Generative and make-on-demand libraries reach novel regions while restricting candidates to molecules that can plausibly be synthesized and tested. section 2.1.2

Library design balances diversity and focus. Diverse selections cover more chemical space and reduce redundant compounds; focused selections concentrate on a chemical series or target-informed region to improve hit rates and reveal structure–activity relationships. section 7.2 section 7.2.1

Antimalarial virtual screening

A screen can begin with more than 212,000 commercially available small molecules from the SPECS repository, filter unsuitable candidates, and compare survivors with 400 known Plasmodium falciparum actives from Malaria Box using similarity searching. section 2.1.2

The right library depends on the campaign: broad screens favor diversity when target information is limited, while focused libraries favor exploitation when biological knowledge is stronger. Drug-like properties, synthesis, purchasing, and assay capacity also constrain selection. section 7.2.1

How Build AI Drug Discovery Pipelines covers it

How deep it goes
Explains library sourcing, molecular quality checks, descriptors, and diversity–focus decisions, but stops short of detailed screening algorithms.
Examples
Uses the SPECS catalog, Malaria Box actives, commercial vendors, enumerated analogs, and diverse or focused chemical-series selections.
What it assumes
Assumes basic molecular datasets and screening goals, while introducing library sourcing, quality safeguards, descriptors, diversity, and focus.
What you can do after
Apply it via virtual-screening workflows that load, validate, filter, describe, and prioritize molecules for testing.
How it connects
Connects compound libraries to virtual screening, similarity searching, clustering, chemical space, structure–activity relationships, and generative modeling.

Related concepts

This explainer was generated by Manning's knowledge graph from the text of Build AI Drug Discovery Pipelines. The section links point to the parts of the book it draws on.